REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,000 | -22.7% | 1,400 | -33.1% | 0.00% | – |
| Q2 2023 | $22,000 | +266.7% | 2,093 | +230.6% | 0.00% | – |
| Q1 2023 | $6,000 | -40.0% | 633 | -7.2% | 0.00% | – |
| Q4 2022 | $10,000 | +25.0% | 682 | +9.1% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 625 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 625 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -55.0% | 625 | -30.8% | 0.00% | – |
| Q4 2021 | $20,000 | -42.9% | 903 | -32.0% | 0.00% | – |
| Q3 2021 | $35,000 | -12.5% | 1,328 | +4.7% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 1,268 | -6.5% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 1,356 | +86.0% | 0.00% | – |
| Q4 2020 | $25,000 | +316.7% | 729 | +264.5% | 0.00% | – |
| Q3 2020 | $6,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |